(Q46892229)

English

Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16409439

Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16409439

Alzheimer's disease

0 references

author name string

Dantoine T

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16409439

Auriacombe S

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16409439

Sarazin M

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16409439

Becker H

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16409439

Pere JJ

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16409439

Bourdeix I

6

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16409439

publication date

1 January 2006

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16409439

International Journal of Clinical Practice

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16409439

60

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16409439

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16409439

110-118

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16409439

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2005.00769.X

21 January 2018

The Global Deterioration Scale for assessment of primary degenerative dementia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2005.00769.X

21 January 2018

The ten point clock test: a quick screen and grading method for cognitive impairment in medical and surgical patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2005.00769.X

21 January 2018

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2005.00769.X

21 January 2018

Identifiers

10.1111/J.1368-5031.2005.00769.X

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16409439

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16409439

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46892229&oldid=2136899931"